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Background- Pulse wave velocity (PWV) is a non-invasive measure of arterial 
stiffness, and a recognised predictor of cardiovascular morbidity and mortality. Given this, it 
is likely that investigating the determinants of PWV will improve our understanding of 
cardiovascular health. At present, there is disagreement regarding the relationship between 
dietary sodium and potassium intakes, and PWV. Hence, further research is needed in order to 
confirm whether dietary sodium and potassium are determinants of PWV.  
Objective- The aim of this cross-sectional study was to investigate the associations 
between dietary sodium and potassium intake, and PWV in the general population.  
Methods- This cross-sectional study used baseline data from Health And Bread 
Intervention Trial (HABIT). Spot urine samples were used to estimate dietary sodium and 
potassium intake. Weighed three-day diet records were analysed for self-reported dietary 
sodium and potassium intake.  Brachial blood pressure, and carotid-femoral PWV were 
measured with the SphygmoCor 2000. 
Results- Sixty-five HABIT participants were included in this study. Overall, 52.3% 
were males, with a mean±SD age of 34.5±18.3years, body mass index (BMI) of 
24.9±4.5kg/m2; BP of 126.5/74.8±17.7/11.2mmHg, and PWV of 7.2±1.6m/s. Mean sodium 
intakes as assessed by spot urine samples and diet records were above New Zealand’s Upper 
Limit of 2300mg/day (urinary sodium: 3021±756mg/day; dietary sodium: 
2784±1067mg/day). Mean potassium intakes, also assessed by spot urine samples and diet 
records, were below the Adequate Intake for New Zealand of 3800mg/day for males and 
2800mg/day for females (male, urinary potassium: 2002±386.9mg/day; male, dietary 
potassium: 3500±1242.2mg/day; female, urinary potassium: 1902.6±428.5mg/day; female, 
dietary potassium: 2783.3±991.3mg/day). Dietary intakes of sodium, potassium, and sodium-
to-potassium ratio as assessed by spot urine samples and diet records were not independently 
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associated with PWV. In multi-variate analysis age was positively associated with PWV (a 1-
year increase in age was associated with a 0.05 m/s increase in PWV).  
Conclusions- This small cross-sectional study found dietary intakes of sodium, 
potassium, and sodium-to-potassium were not independent predictors of PWV, suggesting the 
prediction of PWV is multi-factorial. Future adequately-powered studies should examine 
these relationships. 
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1 - INTRODUCTION 
 
Pulse wave velocity (PWV) is a non-invasive measure of arterial stiffness (Laurent et 
al. 2006; van Bortel et al. 2012). Arterial stiffness describes the inability of arteries to expand 
and contract, which can contribute to an increase in systolic pressure (Wilkinson et al. 1998), 
and manifest as hypertension (>140/90 mmHg) (Zieman, Melenovsky and Kass 2005). Given 
the relationship between PWV and arterial stiffness, PWV is a recognised predictor of 
cardiovascular morbidity and mortality (Mancia et al. 2013).  
Cardiovascular disease (CVD) is the leading cause of death in New Zealand (Ministry 
of Health 2015). The high number of CVD deaths highlights the importance of understanding 
the disease. As PWV is significantly associated with cardiovascular health outcomes, 
investigating the determinants of PWV could improve our understanding of CVD, and 
possibly identify prevention and treatment strategies. Age, hypertension and diabetes are 
known determinants of PWV (Zieman et al. 2005), however, little is known about the dietary 
determinants of PWV – for example whether dietary electrolytes determine PWV.   
 Sodium is important for maintaining extracellular volume, the active transport of 
molecules, and the depolarisation of cells (Robinson 2012), and is primarily found as sodium 
chloride in processed foods (e.g. bread, cheese, sauces), and as table or cooking salt (National 
Health and Medical Research and Ministry of Health 2006). New Zealand’s Ministry of 
Health reports an Upper Limit of 2300mg per day (National Health and Medical Research and 
Ministry of Health 2006). However, the most recent research on a sample of New Zealand 
adults indicates males are consuming an average of 3865mg per day and females an average 
of 2934mg per day (McLean et al. 2015), which are both above the  Upper Limit. Excessive 
consumption of sodium is associated with elevated blood pressure (Polonia et al. 2006) and 
the development of cardiovascular disease (Lennon-Edwards, Schellhardt, Ferreira, 
Farquharand and Edwards 2014). However, there is disagreement in the literature about 
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sodium’s effect on PWV (i.e. arterial stiffness), with studies suggesting a positive relationship 
(e.g. He et al. 2009; Sonada, Takase, Dohi and Kimura 2012) and others no relationship (e.g. 
Dickinson and Keogh 2013; Gijsbers et al. 2015) (for further details see section: 2.3 dietary 
sodium and pulse wave velocity). 
  Potassium is important for the depolarisation and repolarisation of cells (Robinson 
2012) and is found prominently in leafy green vegetables, root vegetables, tree fruit, and vine 
fruit (National Health and Medical Research and Ministry of Health 2006). New Zealand’s 
Ministry of Health reports and Adequate Intake of 3800mg per day for men and 2800mg per 
day for women (National Health and Medical Research and Ministry of Health 2006). 
However, recent data indicates New Zealand’s mean potassium intake was 3031mg per day 
for men and 2436mg per day for women (McLean et al. 2015), which are both below the 
Adequate Intake. It is thought potassium blunts sodium’s effect on blood pressure (Whelton et 
al. 1997) and it is protective against CVD (Lennon-Edwards et al. 2014). However, like 
sodium, there is disagreement in the literature about potassium’s relationship with PWV (i.e. 
arterial stiffness), with studies suggesting no relationship (e.g. Berry, Chowlenczyk and 
Sanders 2010; Garcia-Ortiz et al. 2012) and others suggesting an inverse relationship (e.g. 
Graham, McCance, Young and Mullan 2014; Lennon-Edwards et al. 2014) (for further details 
see section: 2.4 dietary potassium and pulse wave velocity). 
Given the contradictions in the existing literature, there is need for further research 
regarding the relationship between dietary electrolytes and arterial stiffness. This research 
aims to address this discrepancy by undertaking a cross-sectional study to investigate the 




2 - LITERATURE REVIEW  
2.1 - Pulse wave velocity 
2.1.1 – Defining pulse wave velocity 
 
The ejection of blood from the left ventricle into the aorta causes the propagation of 
pressure waves along the arterial tree. Compliant arteries absorb wave energy during systole 
and release it during diastole, which aids coronary perfusion. Some pressure waves are 
reflected back towards the heart and summate with forward-moving waves, producing 
pressure waveforms (Nichols 2011; Wilkinson et al. 1998).   
PWV is the speed at which pressure waves travel. It is defined by the Moens-
Korteweg equation – see below (Nichols 2011). This equation illustrates that PWV is 
inversely related to the elasticity of vessel walls (i.e. greater velocity corresponds to reduced 
elasticity). Therefore, PWV can be used to measure arterial stiffness (Laurent et al. 2006; van 
Bortel et al. 2012), and as a result, PWV is also recognised as a predictor of cardiac morbidity 
and mortality (Mancia et al. 2013) (for further details see section: 2.2 pulse wave velocity and 
health). 
co=√(Eh/2Rρ) a 1 
2.1.2 - Measuring pulse wave velocity  
 
 PWV can be measured by using two pressure catheters placed at a known distance 
from each other, and calculated with the equation below (for further detail see section: 4.5.3 
pulse wave velocity) (van Bortel et al. 2012).  
PWV=d/t b 
Carotid-femoral PWV is the gold standard measure of PWV (Mancia et al. 2013). It 
has been used in landmark studies of arterial stiffness, including the Framingham Heart Study 
																																																								
a	co	represents	PWV,	E	represents	the	vessel’s	modulus	of	elasticity,	h	represents	the	thickness	of	the	





(Mitchell et al. 2004; Tanaka et al. 2009). However, over recent years, brachial-ankle PWV 
has emerged and is being used in clinical settings in Asia (Sugawara and Tanaka 2015). Its 
main advantage over carotid-femoral PWV is that the specialist equipment is easy to use. 
Carotid-femoral PWV requires a technician to manually find a pressure wave, where brachial-
ankle PWV uses four automated blood pressure cuffs (Sugawara and Tanakacal 2015). 
Literature suggests that there is a significant correlation between PWV values recorded by 
both methods, and they predict stroke and coronary artery disease risk comparably (Sugawara 
et al. 2005; Tanaka et al. 2009).   
In practical settings, measurement of the carotid-femoral PWV can be undertaken with 
specialist equipment. The most common are the SphygmoCor 2000, and Complior (Calabia et 
al. 2011). They use different methods to calculate the pulse wave distance (Rajzer et al. 
2008), resulting in slightly different PWV readings. This highlights that uniform principles 
for the measurement of pulse wave distance should be established and used by all researchers. 
Furthermore, until the SphygmoCor 2000 and Complior show comparable results, they should 
use their own cut off values for determining arterial stiffness. The SphymoCor 2000 should 
use values above 10 m/s and the Complior should use values above 12m/s as an indication of 
arterial stiffness (Rajzer et al. 2008, van Bortel et al. 2012).   
A limitation of using the SphygmoCor 2000 and Complior is that it is challenging to 
perform accurately due to the difficulty recording good pressure waves (Calabia et al. 2011). 
The Doppler ultrasound is another method that can be used to measure PWV and it 
overcomes the above limitation.  The Doppler produces an anatomical image that may 
increase the accuracy of the measurement (Calabia et al. 2011). Despite this apparent benefit, 
the literature suggests that the Doppler ultrasound can produce similar PWV results to the 
Complior (Calabia et al. 2011) and the SphygmoCor 2000 (Jiang, Liu, McNeill and  
Chowienczyk 2008).  
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At present, it appears that the measurement method chosen depends on the equipment 
and expertise available. Hence, a variety of measurement tools are used in PWV and health 
literature.     
2.2 - Pulse wave velocity and health 
2.2.1 - Health outcomes associated with pulse wave velocity  
 
Much of the literature agrees that PWV is positively associated with cardiovascular 
event risk (Blacher, Asmar, Djane, London and Safar 1999a; Boutouyrie, Tropeano, Asmar 
and Gautier 2002), cardiovascular mortality (Meaume, Benetos, Henry, Rudnichi and Safar 
2001; Sutton-Tyrrell et al. 2005), and all-cause mortality (Blacher et al. 1999b; Laurent et al. 
2001; Laurent et al. 2003; Mattace-Raso et al. 2006; Mitchell et al. 2010; Vlachopoulos, 
Aznaouridis and Stefanadis 2010; Willum-Hansen et al. 2006).   
The literature exposed one conflicting result. PWV does not always predict all-cause 
mortality in older adults (>70 years of age) (Meaume et al. 2001; Sutton-Tyrrell et al. 2005). 
Sutton-Tyrrell et al. (2005) found the highest PWV quartile had a 70% higher risk of all-cause 
mortality than the lowest PWV quartile, where Meaume et al. (2001) found no association 
between PWV and all-cause mortality. The difference in results may be attributed to the 
marked difference in the number of older adults studied (n=141 (Meaume et al. 2001) versus 
n=2488 (Sutton-Tyrrell et al. 2005)) or the different methods used to measure carotid-femoral 
PWV (Complior (Meaume et al. 2001) versus Doppler ultrasound (Sutton-Tyrrell et al. 
2005)). Even so, only having two studies in this area highlights the need for further 
exploration of the role PWV plays in the health of older adults. 
PWV likely predicts cardiac morbidity and mortality, as it is related to arterial 
stiffness (Laurent et al. 2006; Mancia et al. 2013; van Bortel et al. 2012). Direct measurement 
of arterial stiffness is invasive, and thus is not feasible in humans. Instead, non-invasive 
measures of PWV, like those mentioned previously, are used to estimate arterial stiffness 
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(Blacher et al. 1999a). These measures have been widely used in research and validated in 
both patient and healthy populations (Nichols 2011).  
2.2.2 - Arterial stiffness  
 
Arterial stiffness describes the inability of arteries to expand and contract. It is made 
up of two modifiable aspects: distensibility and compliance. Distensibility is the amount the 
vessel’s diameter changes in relation to its initial diameter. Compliance is the change in the 
vessel’s diameter in response to blood pressure changes. Arterial stiffness is characterised by 
a decline in both distensibility and compliance (O’Rourke et al. 2002). 
Collagen and elastin play a large role in arterial stiffness, as they determine the 
strength and elasticity of vessel walls. In compliant arteries, normal collagen and elastin are 
present, and their production and degradation is in equilibrium. Conversely, their production 
and degradation is not in equilibrium in non-compliant arteries. Instead, there is an 
overproduction of abnormal collagen and a breakdown of normal elastin (Najeeb and Ming-
Hui 2010; Zieman et al. 2005). 
2.2.3 - Factors impacting arterial stiffness 
 
The literature suggests that arterial stiffness is somewhat genetically determined but is 
also influenced by hormones, glycaemic state, endothelial dysfunction and inflammation 
(Najeeb and Ming-Hui 2010).  
Firstly, it is thought that angiotensin II and aldosterone play a role in the development 
of arterial stiffness. Dietary sodium and hyperglycaemic states have been shown to stimulate 
the renin-angiotensin-aldosterone axis.  Increased levels of angiotensin II stimulate the 
production of collagen and the degradation of elastin, reduce nitric oxide synthesis and 
increase reactive oxygen species production. Whereas aldosterone stimulates smooth muscle 
hypertrophy, and fibrosis (Najeeb and Ming-Hui 2010; Zieman et al. 2005). Secondly, 
hyperglycaemic states can cause the production of abnormal collagen and elastin molecules 
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via glycation. The glucose cross-links make collagen stiffer and reduce the elasticity of elastin 
(Najeeb and Ming-Hui 2010; Zieman et al. 2005). Thirdly, researchers believe endothelial 
dysfunction plays a role in arterial stiffness. However, there is no clear consensus regarding 
the mechanism. Currently, the literature suggests that neither one causes the other but both 
play an important role in each other’s development (i.e. a cyclic relationship) (Najeeb and 
Ming-Hui 2010; Zieman et al. 2005). Finally, inflammatory states cause the expression of 
catabolic metalloproteases (MMP). These molecules cause the production of weak collagen 
and frayed elastin, which are both found in non-compliant arterial walls (Najeeb and Ming-
Hui 2010; Zieman et al. 2005).   
2.2.4 - Mechanism linking arterial stiffness and cardiovascular health  
 
In a healthy individual, vessel walls absorb pressure wave energy during systole and 
release energy during diastole, which optimises coronary perfusion (Wilkinson et al. 1998).  
In contrast, non-compliant arteries absorb less wave energy, resulting in the propagation of 
larger and faster waves. These large, fast waves are reflected, and arrive during systole, 
contributing to an increase in systolic pressure (Wilkinson et al. 1998). As a result, arterial 
stiffness manifests itself as hypertension (>140/90mmHg) and elevated pulse pressure 
(systolic blood pressure – diastolic blood pressure) (Zieman et al. 2005).  
There are adverse consequences to chronic hypertension and elevated pulse pressure. 
Firstly, the heart must generate higher systolic pressures to produce the same stroke volume. 
This requires the heart to generate more energy per contraction. Hence, it can stimulate 
ventricular hypertrophy, reducing the efficiency of each cardiac ejection (Zieman et al. 2005). 
Additionally, when reflected pressure waves arrive in systole, coronary perfusion will start in 
systole. This causes a decline in coronary perfusion, which is further exacerbated by a cardiac 
event (Zieman et al. 2005). Finally, at the periphery, arterial stiffness and the associated 
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increase in pulse pressure causes turbulent blood flow. This increases the shear stress and 
pressure on vessel walls, which causes endothelial dysfunction (Zieman et al. 2005). 
 From the literature discussed above, we can conclude that PWV is associated with 
cardiovascular outcomes due to its relationship with arterial stiffness. Therefore, it is 
important to investigate the determinants of PWV (e.g. dietary determinants) to improve our 
understanding of cardiovascular disease. 
2.3 - Dietary sodium and pulse wave velocity  
2.3.1 – Proposed mechanism linking dietary sodium and pulse wave velocity 
 
The mechanism linking sodium and PWV is unknown. Researchers speculate that 
sodium may promote fibrotic changes to arterial walls via aldosterone. This is supported by 
an observational study that suggests PWV is only elevated in high sodium, high aldosterone 
participants, and PWV is normal in high sodium, low aldosterone participants (Kotliar et al. 
2014). Additionally, there is evidence to suggest that sodium may increase arterial stiffness 
via matrix MMP-9 , which is involved in the remodelling of collagen and elastin in the vessel 
wall (Todd et al., 2010). The literature also supports the role of marinobufagenin (MBG) in 
promoting arterial stiffness in response to high sodium intakes. MBG is produced in response 
to the ingestion of salt, and it inhibits Na/K ATPase to increase urinary sodium excretion. A 
consequence of this is the stimulation of vasoconstriction and oxidative stress, which may 
lead to arterial stiffness (Jablonski et al. 2013).  At present, this is a relatively new area of 
research and hence it is unclear which mechanism(s) if any influence PWV.  
2.3.2 - Association between dietary sodium and pulse wave velocity 
 
 Observational evidence supports a relationship between dietary sodium intake and 
PWV (Garcia-Ortiz et al. 2012; Polonia et al 2006; Sonoda et al. 2012). However, there is 
some debate as to whether the relationship between sodium and PWV is positive (Polonia et 
al. 2006; Sonoda et al. 2012) or J-shaped (Garcia-Ortiz et al. 2012). It is likely these different 
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conclusions are a result of different study methodologies. The two studies that found a 
positive relationship between sodium and PWV used urinary sodium excretion to measure of 
dietary sodium intake (Polonia et al. 2006; Sonoda et al. 2012). In contrast, the study that 
found a J-shaped relationship between sodium and PWV used a food frequency questionnaire 
(FFQ) to assess dietary sodium (Garcia-Ortiz et al. 2012). Dietary intake measures have 
different limitations and hence, this difference could explain the inconsistent findings For 
instance, FFQ is associated with a high rate of under and over reporting, which impacts the 
validity of results and thus it is the least accurate method of dietary intake assessment 
(McLean 2014) (for further details see section: 2.6 measuring dietary sodium and potassium 
intake).  
2.3.3 - Effect of dietary sodium on pulse wave velocity 
 
 As with the observational studies, intervention trials have shown mixed results for a 
relationship between dietary sodium and PWV (for further detail see: table 1).  
The majority of intervention studies have shown that sodium intake has no effect on 
PWV in pre-hypertensive or normotensive individuals (Dickinson et al. 2013; Dickinson et al. 
2009; Gijsbers et al. 2015; Todd et al. 2012; Wang et al. 2014). Studies utilised an 
intervention with high sodium groups consuming 3450mg to 7079mg of sodium per day for 
one to six weeks. It is unlikely the null findings were due to study duration, as three of the 
five trials conducted an intervention for four weeks or more (Dickinson et al. 2013; Gijsbers 
et al. 2015; Todd et al. 2012), and changes in arterial stiffness can be seen as early as this 
(Todd et al. 2010).  Furthermore, all studies saw a significant increase in sodium excretion 
(urinary sodium was 1050-3474mg/24-hours higher and sodium/creatinine was 9.6 units 
higher than low sodium groups), which suggests adherence to the intervention (Gijsbers et al. 
2015; Todd et al. 2012; Wang et al. 2014).  
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In contrast to the above findings, several other research groups found sodium intake is 
positively associated with PWV (Avolio et al. 1986; He et al. 2009; Jablonski et al. 2013; 
Seals et al. 2001; Todd et al. 2010). Studies conducted interventions with high sodium groups 
consuming 3600 to 4600mg of sodium per day and found the high sodium groups had a 0.35-
1.43m/s higher PWV than the low sodium groups. The reason why these research groups 
found a positive relationship, which contradicts other research remains unclear. 
At present, there is not enough conclusive evidence to draw the exact relationship 
between dietary sodium and PWV, which is similar to the conclusions drawn from the dietary 
potassium and PWV literature.  




Intervention Design n Population Dose Duration Outcome 
measures 
Results Effect size 
Dickinson, 
2013 
Low Na diet  Rct, sb 
 
Not pc 




Low Na diet 
(2340mg Na per 
day, from diet), 
versus high Na 
control diet 
(3510mg Na per 
day, from diet 
and supplement) 








• Urinary Na 
significantly 
lower on low Na 
diet than control 
diet 
• PWV was not 
significantly 







At week 6: 
• High Na 
9.6±2.9m/s, 




Low Na diet Rct  
 
Not pc, db 




Low Na diet 
(1150mg Na per 
day, from diet), 
versus high Na 
control diet 
(3450mg Na per 
day, from diet) 








• Urinary Na 
significantly 
lower on low Na 
diet than control 
diet 
• PWV was not 
significantly 







At week 2: 
• High Na 
10.5±3.1m/s, 









Rct, db, pc 36 Pre-
hypertensive 
adults 
Low Na control 
diet (2300mg K 
and 2400mg Na 




(5400mg Na per 




(5124mg K per 























• PWV not 
significantly 












At week 4: 
• High Na 
13.1±2.9 m/s, 
versus low Na 
13.1±3.0m/s 
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Todd, 2012 Na 
supplement 
(tomato juice) 
Rct, sb, pc 25 Normotensive 
adults 
Low Na control 
diet (1380mg Na 






































higher with high 
Na supplement 
than control diet 
• PWV was not 
significantly 
affected by either 
intervention 













At week 4: 





versus high Na 
7.0±1.2m/s 
Wang, 2014 High Na diet 
(added salt to 












Low Na control 
diet (1180mg Na 
per day, from 
diet), versus 
high Na diet 
(7079mg Na per 
day, from diet), 
versus high Na 
diet with K 
supplement 
(7079mg Na and 






versus 1 week 
high Na diet, 
versus 1 week 





• Urinary Na 
significantly 
higher with high 
Na diet than 
control diet 
• Urinary K 
significantly 
higher with K 
supplement than 
control diet 
• PWV was not 
significantly 












In 1 week: 
• Low Na 
reduced by 
14.4±103.4cm/
s, versus high 
Na reduced by 
25.2±103cm/s 











Low Na diet, 
versus high Na 
control diet (mg 
Na not reported, 
as voluntary), 
24.8 months 







to tibial PWV, 
and brachial to 
radial PWV 
• Urinary Na 
significantly 
lower on low Na 




lower in all three 
locations on low 







• Not quantified 
He, 2009 Low Na diet Rct, db, pc 169 Hypertensive 
adults 
Low Na diet 
(1955mg Na per 
day, from diet 
and placebo), 
versus high Na 
control diet 












• Urinary Na 
significantly 
lower on low Na 




lower on low Na 





blacks on low Na 
diet than control 
diet 
• PWV not 
affected by low 








At week 6: 
• All: high Na 
11.5± 2.3m/s, 
versus low Na 
11.1±1.9m/s 
• Black: high Na 
11.7±2.0m/s, 
versus low Na 
11.2±1.8m/s 
• White: high Na 
11.3±2.6 m/s, 
versus low Na 
11.1±1.9m/s 
• Asian: high Na 
11.3±2.2m/s, 





Low Na diet Rct, db, pc 11 Pre-
hypertensive 
adults 
Low Na diet 
(1500mg Na per 
day, from diet 
and placebo), 
versus high Na 
control diet 
(3600mg Na per 
day, from diet 
and supplement) 












lower with low 
Na diet than 
control diet  
• N/A 
 
At week 5: 
















Low Na diet 
(2300mg Na per 














• Urinary Na 
significantly 
lower on low Na 
diet than on 
exercise 
• Aortic to femoral 
PWV 
significantly 
lower on low Na 
diet than on 
exercise 
• Brachial to radial 
PWV was not 







In 3 months: 









Todd, 2010 Na 
supplement 
(tomato juice) 
Rct, sb, pc 35 Hypertensive 
adults 
Low Na control 
diet (1380mg Na 

































higher with high 
Na supplement 
























low Na  
• PWV 
significantly 
higher with high 
Na supplement 
than low Na 
 
At week 4: 










1 n = sample number, Na = sodium, K = potassium, rct = randomised crossover study, db = double blinded, pc = placebo controlled, sb = single blinded, PWV = pulse wave 
velocity, 24h = twenty-four hours, NA = not applicable
2.4 - Dietary potassium and pulse wave velocity 
2.4.1 - Association between dietary potassium and pulse wave velocity  
 
 Few observational studies investigated the relationship between dietary potassium 
intake and PWV. Furthermore, there is little consensus regarding the relationship, with some 
findings supporting an inverse relationship between potassium and PWV (Dart and Qi 1995; 
Lennon-Edwards et al. 2014) and others suggesting there is no relationship (Garcia-Ortiz et 
al. 2012).  
2.4.2 - Effect of dietary potassium on pulse wave velocity 
 
Although few observational studies have been published, there are many intervention 
studies adding to the body of evidence regarding the relationship between dietary potassium 
and PWV. Intervention studies have reported inconsistent effects of high potassium diets on 
PWV (for further detail see: table 2). The majority of studies conclude that potassium 
supplementation has no effect on PWV (Berry et al. 2010; Blanch, Clifton, Petersen, 
Willoughby and Keogh 2014; Gijsbers et al. 2015; Wang et al. 2014); however, some report a 
reduction (Graham et al. 2014; He et al. 2010) and others an increase in PWV (Matthesen, 
Larsen, Vase, Lauridsen and Pedersen 2012). 
 There are some methodological differences that may explain the inconsistencies in 
results. The study that found an increase in PWV used the largest potassium supplement dose, 
of 3900mg per day in addition to the diet (Matthesen et al. 2012). Hence, this study may 
suggest large doses of potassium are detrimental to PWV. However, Matteson recruited the 
smallest sample size (n=21) (Matthesen et al. 2012). A power calculation was not given, but 
the study may have been underpowered and produced a result that we must interpret with 
caution. Furthermore, the studies that found no relationship between potassium and PWV, 
either supplemented participants’ diets with high potassium foods (rather than supplements) 
(Berry et al. 2010; Blanch et al. 2014), or used a high sodium diet in their crossover design 
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(Gijsbers et al. 2015; Wang et al. 2014). All of which may have attenuated the effect 
potassium has on PWV.  Adding to this, the studies that found a reduction in PWV both used 
a supplement dose of 2496mg of potassium (on top of usual intake) per day (Graham et al. 
2014; He et al. 2010), and the trials that found no change added 780 to 2824mg of potassium 
per day to their participant’s usual diet (Berry et al. 2010; Blanch et al. 2014; Gijsbers et al. 
2015; Wang et al. 2014). This difference may imply that 2496mg of potassium per day is the 
optimal dose for the reduction of arterial stiffness. However, the difference in dose may only 
be accounting for some of the variation in results.  
2.4.3 – Possible mechanism linking dietary potassium and pulse wave velocity  
 
  There is no clear mechanism explaining how potassium is linked to PWV and arterial 
stiffness. Currently, the literature supports two main theories. Firstly, high potassium levels 
may improve endothelial function by increasing nitric oxide synthesis, which causes 
vasodilation in response to shear stress (Blanch et al. 2014; He et al. 2010; Lennon-Edwards 
et al. 2014). However, Blanch, Clifton and Keogh (2015) did not find biomarker evidence to 
support this theory. Secondly, researchers suggest that potassium may reduce arterial stiffness 
via improvements in blood pressure (Blanch et al. 2015; Graham et al. 2014; Lennon-
Edwards et al. 2014). However, it seems that this relationship has only been found in 
individuals with high cardiovascular disease risk (Blanch et al. 2015).  
The lack of consensus regarding the mechanism linking dietary potassium and PWV 
supports the lack of consensus amongst observational and intervention studies that a link even 
exists. Therefore, no conclusions can be formed until further exploration in this area has been 
conducted   
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At day 28: 
• Control 
5.6±0.7m/s, 
versus high K 
5.9±0.8m/s 
1 n = sample number, Na = sodium, K = potassium, rct = randomised crossover study, db = double blinded, pc = placebo controlled, sb = single blinded, PWV = pulse wave 
velocity, 24h = twenty-four hours 
2.5 - Dietary sodium-to-potassium ratio and pulse wave velocity  
 
There is evidence to suggest the dietary sodium-to-potassium ratio is a better predictor 
of cardiovascular disease outcomes (Castro and Raij 2013) and more strongly associated with 
blood pressure than the individual electrolytes (Tabara et al. 2015). In light of this research, 
there is the notion that the dietary sodium-to-potassium ratio may also have a stronger 
relationship with PWV.  
The research groups that have investigated the association between the dietary 
sodium-to-potassium ratio and PWV have produced inconsistent results.  Most of the 
evidence is observational, and does not support a relationship between the dietary sodium-to-
potassium ratio and PWV (Lennon-Edwards et al. 2014; Redelinghuys et al. 2010; Tabara et 
al. 2015; Wang et al. 2014). However, two observational studies suggest the ratio is more 
strongly correlated with PWV than individual electrolytes (Garcia-Ortiz et al. 2012; Wei-
Zhong, Ning-Ling and Hong-Yi 2012). Garcia-Ortiz et al. (2012) and Wei-Zhong et al. (2012) 
recruited hypertensive, diabetic participants, where the other studies recruited healthy 
samples. It is likely the response of a hypertensive, diabetic sample differs from a healthy 
sample. Therefore, sodium loading, with consistently low potassium intakes may only impact 
the arterial stiffness of populations at risk of cardiovascular disease. However, there is not 
enough consistent evidence to draw the exact relationship between the dietary sodium-to-
potassium ratio and PWV.  
2.6 - Measuring dietary sodium and potassium intake  
2.6.1 - Urinary assessment 
 
 Twenty-four-hour urine sampling is used to calculate dietary potassium and sodium 
intake. It is calculated by multiplying total urine volume by urine-sodium concentration (Land 
et al. 2014). This method is the gold standard measure of dietary sodium (McLean 2014; Wen 
et al. 2015; Wielgosz et al. 2016) and potassium intake (Mizéhoun-Adissoda et al. 2016). This 
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is because the kidneys excrete approximately 90% of ingested sodium (Holbrook et al. 1984; 
McLean 2014; Wielgosz et al. 2016) and approximately 77% of ingested potassium 
(Holbrook et al. 1984; Mizéhoun-Adissoda et al. 2016). Unfortunately, 24-hour urine 
collection is burdensome and thus many participants return incomplete samples (Bentley 
2006; McLean 2014; Wielgosz et al. 2016). No researcher has formulated an accurate method 
to overcome this limitation (Huang et al. 2014; McLean 2014; Wielgosz et al. 2016). 
Therefore, repeating samples, which is costly, is the only way to increase the accuracy of 
results (Bentley 2006; Huang et al. 2014).  
 Spot urine samples are less burdensome than 24-hour urine sampling. It only requires 
the collection of one urine sample in a day and hence it is very convenient and affordable. 
However, researchers are still looking at how well this predicts actual dietary sodium and 
potassium intake (McLean 2014). There are three traditional equations used to calculate 
estimated 24-hour sodium excretion from spot urine samples (Peng et al. 2016). From these 
studies, we can conclude that no matter the equation used to estimate 24-hour sodium, all 
three will correlate comparably with actual 24-hour sodium (Brown et al. r=0.505; Kawasaki 
et al. r=0.531; Tanaka et al. r=0.54) (Brown et al. 2013; Kawasaki, Itoh, Uezono and Sasaki 
1993; Tanaka et al. 2002). The same is true for estimated 24-hour potassium (Kawasaki et al. 
r=0.443; Tanaka et al. r=0.56) (Kawasaki et al. 1993; Tanaka et al. 2002). However, a recent 
study concluded that all methods are still relatively inaccurate, and hence, more accurate 
methods are needed before population sodium intakes can be estimated from spot urine 
samples (Peng et al. 2016).   
2.6.2 - Dietary assessment  
 
Dietary assessment is a useful tool, as it not only quantifies dietary intake, but can be 
used to identify foods associated with high or low intakes (e.g. high sodium diets associated 
with high processed food intake (e.g. cheese, sauces)) (McLean 2014). Most of the literature 
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regarding dietary assessment of electrolyte intake focuses on measuring sodium, and the 
general consensus is that for sodium, dietary assessment is less accurate than 24-hour-urine 
sampling. This is likely because participants find it difficult to accurately measure salt added 
during cooking or at the table, participants misreport foods and portion sizes, and research 
assistants find it difficult to quantify sodium in home-cooked and processed foods as the 
sodium content can vary greatly (McLean 2014; Bentley 2006).  
Out of the four dietary assessment methods, weighed diet records are considered the 
most accurate form of dietary assessment (Bentley 2006). A possible reason for this is diet 
records analyse current diet, as they are used prospectively, and they analyse usual intake, as 
multiple days are usually sampled (Bentley 2006). Huang et al. (2014) supports this, as they 
found diet records, in comparison to 24-hour sampling, only under-estimated sodium intake 
by 2%, where 24-hour diet recalls and FFQ under-estimated sodium intake by 8% and >10%, 
respectively. However, Huang et al. (2014) also found diet records were less accurate for 
measuring potassium and the sodium-to-potassium ratio than for measuring sodium. This is 
likely showing the limitations of using diet records. Some general limitations are than diet 
records require participants to be literate and numerate for accurate records, and highly 
motivated to overcome the high participant burden. Furthermore, many participants misreport 
or forget items and this often leads to incorrect estimation of dietary intake (Bentley 2006; 
McLean 2014).  
In comparison to diet records, twenty-four-hour diet recalls are easy to administer, and 
usually have a high response rate, as participant burden is low (Bentley 2006). Unfortunately, 
24-hour diet recall estimations of dietary sodium and potassium intake correlate weakly with 
24-hour urine samples.  Studies found correlation coefficients range from 0.16-0.46 for 
dietary sodium intake, and from 0.29-0.39 for dietary potassium intake (Mercado et al. 2015; 
Wen et al. 2015). An explanation for this is that 24-hour diet recalls are conducted by 
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interviewers, who can create bias (Bentley 2006). Additionally, 24-hour diet recalls do not 
account for day-to-day diet variation and hence, the results do not depict usual intake (Bentley 
2006).  
FFQ is a useful dietary assessment method for collecting data from large groups on 
usual intake, as they ask participants to answer questions about their diet over a long time 
period (McLean 2014). However, it is the least accurate method of dietary assessment. When 
measuring sodium and potassium intake, FFQ error is not only greater, but varies two times 
more than diet record error (Day, McKeown, Wong, Welch and Bingham 2001). One 
explanation for this is the prevalence of under and over reporting (McLean 2014). With this in 
mind, FFQ results must be interpreted with caution when reviewing literature. 
2.7 - Summary 
 
This literature review explored PWV and its possible association with dietary sodium 
and potassium intake. The first and second section defined PWV, a non-invasive measure of 
arterial stiffness, and highlighted that PWV is positively associated with cardiovascular 
morbidity and mortality. The third, fourth, and fifth section highlighted that there is 
disagreement regarding the relationship between dietary sodium, potassium, or sodium-to-
potassium and PWV. Finally, the sixth section highlighted that all measures of dietary 
electrolyte intake have strengths and limitations that must be considered due to their impact 








3 - OBJECTIVE STATEMENT 
 
 
The overall objective of this cross-sectional study was to investigate associations between 
sodium and potassium intake and PWV in the general population. 
   
The specific aims were to: 
1. Examine the association between sodium intake and PWV in the general 
population 
2. Examine the association between potassium intake and PWV in the general 
population 






























4 - PARTICIPANTS AND METHODS  
4.1 - Study design 
 
This cross-sectional study was part of the Health And Bread Intervention Trials 
(HABIT) study, which was conducted in Dunedin, New Zealand, between January 2015 and 
December 2016. The aim of HABIT is to determine if changing the composition of bread, so 
it is lower in sodium, higher in nitrate (beetroot), or higher in L-arginine (nut) alters markers 
of cardiovascular disease in the general population.  HABIT is a 12-week, randomised, 
controlled, parallel intervention trial with four arms – low sodium, beetroot, nut, or normal 
control bread. Participants were asked to continue with their usual diet, while substituting 
their usual bread for the study bread.  
 This cross-sectional study aimed to investigate the association between sodium and 
potassium intake, and PWV in the general population using the baseline data collected for the 
HABIT study. 
4.2 - Ethics 
 
The study received ethical approval from the University of Otago Human Ethics 
Committee (Health) in 2014 (H14_144). Prior to screening for eligibility, the participants 
were informed of the purpose and protocols of the study. If they felt they required more 
information, they were encouraged to discuss it further. Participants that chose to volunteer 
gave informed written consent to participate prior to any data collection. 
4.3 - Participants 
4.3.1 - Sample size 
 
HABIT aimed to recruit 200 adult participants – 50 participants per intervention. This 
allowed HABIT to detect a clinically meaningful difference in systolic blood pressure (SBP) 
between any two groups, assuming a standard deviation of 0.8 or lower, a correlation between 
baseline and follow-up of r=0.85 or higher, with 80% power to detect an effect size using a 
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two-sided test at the 0.05 level, and allowing for a dropout rate of 10%. For the present study 
all participants recruited at the time of analysis were included in the study.   
4.3.2 - Recruitment  
 
HABIT participants were recruited via a database of previous study participants, 
community papers, local newspapers, flyers in shops, and via social media. Participants were 
recruited between January 2015 and December 2016.  
4.3.3 - Eligibility 
 
HABIT recruited participants from the general population, who were over 18 years of 
age, and reported they consumed four to six slices of bread per day.   
 Participants were excluded if they had a chronic disease (e.g. cancer, cardiovascular 
disease, diabetes), had food allergies, were on a energy-restricted diet, were under 18 years of 
age, were pregnant or lactating, consumed less than four slices of bread per day, or had an 
incomplete data set (i.e. missing a PWV measure, spot urine sample or diet record).   
As of January 2016, sixty-five participants were eligible to participate in the study.   
4.4 - Experimental protocol  
 
Participants attended clinic visits at the University of Otago, Human Nutrition clinic. 
All visits occurred in the morning (0700-1000). This thesis utilized baseline visit one and two 
data (before any intervention was undertaken). Baseline visit one occurred two weeks prior to 
starting the intervention, and baseline visit two occurred the day before starting the 
intervention. At baseline, demographic data wer collected, anthropometric measures were 
taken, blood pressure was measured, carotid-femoral PWV was measured, and spot urine 
samples were collected. Participants were also given weighed-diet record equipment, and an 
accelerometer. They were taught how to complete the weighted diet record and use the 
accelerometer accurately. They returned their weighed-diet record and accelerometer at their 
next clinic visit. 
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4.5 - Outcome measures 
4.5.1 - Anthropometry 
 
 Height was measured with a stadiometer, with the participant’s head in the Frankfort 
plane and their heels against the wall. Weight and body composition was measured with a 
segmental body composition analyser (BC-418, Tanita, Illinois, United States of America). 
Height and weight were used to calculate body mass index (BMI=weight (kg) / height (m)2).   
4.5.2 - Blood pressure  
 
 The SphygmoCor 2000 (manufactured by AtCor Medical Pty Ltd, Sydney, Australia) 
was used to measure systolic and diastolic blood pressure. The equipment and software was 
calibrated annually, using the calibration kit provided by AtCor Medical Pty Ltd. 
 At all clinic visits, participants were asked to lie in the supine position, and rest for at 
least five minutes prior to the measurement. Firstly, the brachial cuff was positioned around 
the participant’s upper arm, and was aligned with their brachial artery. The cuff was inflated, 
and systolic and diastolic blood pressure was measured automatically. Blood pressure was 
reported as the average of the three consecuative recordings at baseline.  
4.5.3 - Pulse wave velocity 
 
The SphygmoCor 2000 was also used to measure carotid-femoral PWV. As 
mentioned previously, the equipment and software was calibrated annually. 
At all clinic visits, participants were asked to lie in the supine position, and rest for at 
least five minutes prior to the measurement. Firstly, the femoral cuff was positioned at the 
highest point on the participant’s thigh. Secondly, a tape measure was used to measure the 
distance from the sternal notch to the femoral site (i.e. at the femoral cuff), and from the 
sternal notch to the carotid site (i.e. where the carotid pulse can be palpated). These two 
distances were entered into the SphygmoCor software, and the distance the pressure wave 
travelled along the aorta (d) was calculated automatically. Thirdly, the tonometer was held at 
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the carotid site to record carotid pressure waves, and the femoral cuff was used to record 
femoral pressure waves. The time difference between the beginning of the carotid pressure 
waves and the beginning of the femoral pressure waves was measured automatically (t). 
Finally, the SphygmoCor software calculated PWV with the equation below (AtCor Medical 
2012). PWV was presented as the average PWV of the two consecutive recordings at 
baseline. 
PWV = d/t 
4.5.4 - Spot urine samples 
 
 At all clinic visits, participants were asked to complete a single-void morning urine 
sample. Their urine was transferred into a 20mL storage container. These were frozen at -20 
degrees Celsius until later analysis.  
From these samples, urinary sodium, potassium and creatinine excretion were 
measured. On the Cobas c 311 (manufactured by Roche, Rotkreuz, Switzerland), urinary 
sodium and potassium were measured using the ion selective electrode, and urinary creatinine 
was measured using the calorimetric assay. Urinary sodium, potassium and creatinine were 
used to estimate dietary sodium and potassium intake via the Tanaka method - see equation 
below (Tanaka et al. 2002; Hooft van Huysduynen et al. 2014; Toft et al. 2014).  
Predicted 24-hour creatinine = (-2.04*age (year))+(14.89*weight (kg))+(16.14*height 
(cm)) – 2244.45 
 
Estimated 24- hour sodium intake = 21.98*(X 0.392) 
X = (spot urine sodium/spot urine creatinine)*predicted 24-hour creatinine 
 
Estimated 24-hour potassium intake = 7.59*(Y 0.431) 
Y = (spot urine potassium/spot urine creatinine)*predicted 24-hour creatinine 
 
4.5.5 - Diet records 
 
 Prior to starting the intervention, HABIT participants were asked to complete a non-
consecutive three-day weighed diet record, which included at least one weekend day. They 
were provided with electronic scales (Salter Housewares, HoMedics Group Ltd., Kent, United 
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Kingdom) a diet record book, and portion size photos. In addition to this, they were instructed 
on how to complete their weighed diet record by a nutritionist or dietitian. Participants were 
asked to record food and fluid intake at the time of consumption and return their diet record at 
the next clinic visit. At this visit, the records were checked, and any clarifications were 
requested. 
Diet record data were entered into Kaiculator (2011). The listed foods were matched 
to the same or a similar food in the Kaiculator database (e.g. ‘brown bread’ matched with 
‘bread, wholemeal/wheatmeal’). Following this, the portion sizes were entered as weights, 
volumes or measure descriptors (e.g. two slices). Once all listed foods and portions were 
entered, Kaiculator (2011) calculated the nutrient composition of the diets using food 
composition data from 2014 Plant and Food Research. Dietary energy, carbohydrate, protein, 
fat, sodium, and potassium intake were reported as the average of the three reported days.  
4.5.6 - Accelerometer 
 
 Prior to starting the intervention, HABIT participants were asked to wear an 
accelerometer (New-Lifestyles NL-1000, New-Lifestyles Inc., Lee’s Summit, Missouri, USA) 
for seven consecutive days. This provided information on number of steps per day, distance 
travelled per day, and minutes of physical activity.  The data were reported as the average of 
the seven days. 
4.6 - Statistical analysis  
 
Stata Statistical Software 14.1 (Statacorp LP, College Station Texas, USA) was used 
for all statistical analyses.  
Descriptive, haemodynamic, and intake data was reported as mean and standard 
deviation. A two-sided t-test was performed to detect significant differences between males 
and females. 
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 Univariate linear regression was used to determine the association between electrolyte 
intakes estimated from diet record and urine sample data (i.e. sodium, potassium, sodium-to-
potassium ratio), and PWV. Multivariate linear regression was used to determine the adjusted 
relationship. To build the multivariate model, confounding factors were added individually, 
and were kept in the model if they contributed sufficiently (i.e. percentage of variance 
increased by more than one percent). The confounding factors included were: sex, age, BMI, 
and minutes of physical activity. Fat mass, steps per day, energy intake, fat intake, protein 
intake, and carbohydrate intake were not included in the multivariate model as they did not 
contribute sufficiently. In all models, regression coefficients, 95% confidence intervals and p-
values were calculated for the electrolytes and confounding factors, and residuals of the 

























5 - RESULTS 
5.1 - Participant characteristics 
5.1.1 - Descriptive data 
 
Sixty-five HABIT participants were included in this cross-sectional study. Participant 
characteristics are reported in Table 3, 4 and 5. Table 3 shows there were significant 
differences between males and females for a number of descriptors. Compared to males, 
females weighed significantly less, had significantly more body fat, and reported consuming 
significantly less energy, carbohydrate, protein and fat. There were no significant differences 
for BMI, steps and minutes of physical activity between the sexes. 
 
Table 3: Characteristics of study participants (n=65) 1  





Ethnicity (n (%)) 



















Age (years) 2 34.5 ± 18.3 35.7 ± 18.2 33.0 ± 18.5 0.424 
Weight (kg) 2 73.6 ± 13.9 78.1 ± 12.7 68.5 ± 13.6 0.030 + 
BMI (kg/m2) 2 24.9 ± 4.5 24.6 ± 3.1 25.2 ± 5.7 0.507 

























Body fat (%) 2 26.3 ± 10.5 19.3 ± 6.1 34.1 ± 8.7 <0.001 + 
Steps per day 2 9312.2 ± 4157.6 9612.3 ± 4759.2 8983.1 ± 3427.4 0.553 
Physical activity 
(minutes/day) 2 
62.7 ± 24.4 61.1 ± 26.8 64.5 ± 21.8 0.662 
Smokers (n (%)) 0 (0.0%) 0 (0.0%) 0 (0.0%) - 
Energy intake 
(kJ/day) 2  
9152.9 ± 2915.3 10328.8 ± 2833.6 7863.3 ± 2452.1 <0.001 + 
Carbohydrate intake 
(g/day) 2  
252.3 ± 83.2 285.6 ± 89.8 215.8 ± 57.2 <0.001 + 
Protein intake 
(g/day) 2  
85.3 ± 34.8 100.3 ± 37.9 68.9 ± 21.8 <0.001 + 
Fat intake (g/day) 2  86.2 ± 32.6 96.7 ± 33.8 74.6 ± 27.3 0.012 + 
1 n=number of participants, BMI=body mass index 
2 mean ± standard deviation 




5.1.2 - Haemodynamic data 
 
As shown in Table 4, there were no significant differences between male and female 
haemodynamic data. The average blood pressure was not indicative of hypertension 
(<140/90mmHg (Zieman et al. 2005), and the average PWV did not suggest arterial stiffness 
(<10m/s (Rajzer et al. 2008). 
 
Table 4: Haemodynamic data (n=65) 1 2 





SBP (mmHg)  126.5 ± 17.7 127.1 ± 17.2 125.8 ± 18.4 0.710 
DBP (mmHg)  74.8 ± 11.2 51.3 ± 9.3 51.2 ± 14.0 0.991 
PWV (m/s)  7.2 ± 1.6 7.5 ± 1.9 6.9 ± 1.2 0.243 
1 n=number of participants, SBP=systolic blood pressure, DBP=diastolic blood pressure, PWV=pulse wave 
velocity 
2 mean ± standard deviation 
+ p-value <0.05 indicates a statistically significant difference between males and females 
 
5.1.3 - Urinary and dietary electrolyte intake data 
 
Table 5 shows there were significant differences between male and female electrolyte 
data. Females had a significantly lower potassium intake as assessed by diet records than 
males. Furthermore, females had a significantly lower sodium intake as assessed by diet 




















Table 5: Urinary and dietary electrolyte intake data (n=65) 1 2 





Urinary Na intake 
(mg/day) 3 
3021.3 ± 755.9 3204.2 ± 687.3 2820.6 ± 787.2 0.028 + 
Dietary Na intake 
(mg/day) 4 
2783.7 ± 1067.4 3203.9 ± 1067.9 2322.8 ± 869.7 <0.001 + 
Urinary K intake 
(mg/day) 3 
1954.7 ± 407.2 2002.2 ± 386.9 1902.6 ± 428.5 0.493 
Dietary K intake 
(mg/day) 4 
3158.4 ± 1177.5 3500 ± 1242.2 2783.3 ± 991.3 0.008 + 
Urinary Na:K ratio 
3 
2.7 ± 0.7 1.6 ± 0.4 1.5 ± 0.4 0.147 
Dietary Na:K ratio 
4 
0.9 ± 0.4 1.0 ± 0.4 0.9 ± 0.4 0.267 
1 n=number of participants, Na=sodium, K=potassium 
2 mean ± standard deviation 
3 From spot urine samples (for further detail see: 4.5.4 spot urine samples) 
4 From 3-day weighed diet record (for further detail see: 4.5.5 diet records) 
+ p-value <0.05 indicates a statistically significant difference between males and females 
 
5.2 - Adequacy of electrolyte intakes 
5.2.1 - Sodium 
 
Figure 1 and 2 present male and female sodium intakes in relation to New Zealand’s 
Upper Limit (2,300mg per day for females and males (National Health and Medical Research 
and Ministry of Health 2006)).  The figures show average sodium intakes, measured with diet 
records and spot urine samples, were above the Upper Limit.  
 
Figure 1: Male sodium intakes in relation to New Zealand’s Upper Limit 1 2 
1 Na=sodium 
2 Black line–Ministry of Health advises an Upper Limit of 2,300mg of sodium per day (National Heatlh and 
























Figure 2: Female sodium intakes in relation to New Zealand’s Upper Limit 1 2 
1 Na=sodium 
2 Black line–Ministry of Health advises an Upper Limit of 2,300mg of sodium per day (National Heatlh and 
Medical Research and Ministry of Health 2006) 
 
5.2.2 - Potassium 
 
Figure 3 and 4 present male and female potassium intakes in relation to New 
Zealand’s Adequate Intake (2,800mg per day for females, 3,800mg per day for males 
(National Health and Medical Research and Ministry of Health 2006)). The figures show 
average potassium intakes as assessed by spot urine samples and diet records, were below the 
Adequate Intake.  
 
Figure 3: Male potassium intakes in relation to New Zealand’s Adequate Intake 1 2  
1 K=potassium 
2 Black line-Ministry of Health recommends an Adequate Intake of potassium of 3,800mg per day for 














































Figure 4: Female potassium intakes in relation to New Zealand’s Adequate Intake 1 2  
1 K=potassium 
2 Black line-Ministry of Health recommends an Adequate Intake potassium of 2,800mg per day for 
females (National Health and Medical Research and Ministry of Health 2006) 
 
5.3 - Association between dietary electrolytes, and PWV 
 
Table 6 shows sodium, potassium, and the sodium-to-potassium ratio, measured with 





































Table 6: Predicting pulse wave velocity from dietary electrolyte intake, demographics, anthropometrics, 
and physical activity (n=65) 1 
Variables Regression coefficient (95% CI) p-value + 
4.a Na Model 
Univariate regression 
Dietary Na intake (g) 2 0.17 (-0.21, 0.55) 0.364 
Age- and sex-adjusted regression 
Dietary Na intake (g) 2 0.16 (-0.16, 0.49) 0.318 
Sex -0.28 (-0.97, 0.41) 0.424 
Age (years) 0.06 (0.04, 0.07) <0.001 + 
Multivariate regression 
Dietary Na intake (g) 2 0.15 (-0.17, 0.47) 0.344 
Sex -0.30 (-0.97, 0.38) 0.388 
Age (years) 0.04 (0.02, 0.06) <0.001 + 
BMI (kg/m2) 0.03 (-0.05, 0.11) 0.431 
Physical activity (minutes) -0.01 (-0.03, 0.00) 0.051 
4.b K Model 
Univariate regression 
Dietary K intake (g) 2 0.20 (-0.14, 0.54) 0.246 
Age- and sex-adjusted regression 
Dietary K intake (g) 2 0.09 (-0.20, 0.37) 0.539 
Sex -0.36 (-1.02, 0.30) 0.277 
Age (years) 0.05 (0.04, 0.07) <0.001 + 
Multivariate regression 
Dietary K intake (g) 2 0.11 (-0.17, 0.39) 0.430 
Sex -0.35 (-1.00, 0.30) 0.286 
Age (years) 0.04 (0.02, 0.06) <0.001 + 
BMI (kg/m2) 0.03 (-0.05, 0.11) 0.456 
Physical activity (minutes) -0.02 (-0.03, -0.001) 0.042 + 
4.c Na:K Model 
Univariate regression 
Dietary Na:K ratio 2 -0.17 (-1.23, 0.90) 0.757 
Age- and sex-adjusted regression 
Dietary Na:K ratio 2 0.11 (-0.74, 0.95) 0.802 
Sex -0.41 (-1.05, 0.22) 0.199 
Age (years) 0.05 (0.04, 0.07) <0.001 + 
Multivariate regression 
Dietary Na:K ratio 2 0.00 (-0.83, 0.83) 0.998 
Sex -0.43 (-1.056 0.20) 0.174 
Age (years) 0.04 (0.02, 0.06) <0.001 + 
BMI (kg/m2) 0.03 (-0.05, 0.11) 0.424 
Physical activity (minutes) -0.01 (-0.03, 0.0001) 0.052 
1 Na=sodium, BMI=body mass index, K=potassium 
2 From 3-day weighed diet record (for further detail see: 4.5.5 diet records) 
+ p-value <0.05 indicates a statistically significantly significant association with PWV  
 
5.4 - Association between urinary electrolytes, and PWV 
 
Table 7 shows the sodium-to-potassium-ratio, measured with spot urine samples, was 
not significantly associated with PWV. Individually, sodium and potassium, measured with 
spot urine samples, were significantly associated with PWV. However, the effect sizes were 
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small (a 23mg (1mmol) increase in urinary sodium was associated with a 0.02m/s increase in 
PWV; and a 39mg (1mmol) increase urinary potassium is associated with a 0.04m/s increase 
in PWV), and when adjusted for age, sex, BMI and minutes of physical activity the 
relationships were not significant.  
 
Table 7: Predicting pulse wave velocity from urinary electrolyte intake, demographics, anthropometrics, 
and physical activity (n=65) 1  
Variables Regression coefficient (95% CI) p-value + 
5.a Na Model  
Univariate regression 
Urinary Na intake (per 23mg) 2 0.02 (0.01, 0.03) 0.002 + 
Age- and sex-adjusted regression 
Urinary Na intake (per 23mg) 2 0.01 (-0.004, 0.02) 0.221 
Sex -0.33 (-0.97, 0.32) 0.314 
Age (years) 0.05 (0.03, 0.07) <0.001 + 
Multivariate regression 
Urinary Na intake (per 23mg) 2 0.00 (-0.01, 0.02) 0.366 
Sex -0.35 (-0.99, 0.29) 0.281 
Age (years) 0.04 (0.02, 0.06) <0.001 + 
BMI (kg/m2) 0.02 (-0.06, 0.10) 0.580 
Physical activity (minutes) -0.01 (-0.03, 0.003) 0.054 
5.b K Model 
Univariate regression 
Urinary K intake (per 39mg) 2 0.04 (-0.001, 0.07) 0.058 
Age- and sex-adjusted regression 
Urinary K intake (per 39mg) 2 0.01 (-0.02, 0.04) 0.585 
Sex -0.41 (-1.04, -0.23) 0.205 
Age (years) 0.05 (0.04, 0.07) <0.001 + 
Multivariate regression 
Urinary K intake (per 39mg) 2 0.01 (-0.03, 0.04) 0.765 
Sex -0.41 (-1.05, 0.23) 0.202 
Age (years) 0.04 (0.02, 0.06) <0.001 + 
BMI (kg/m2) 0.02 (-0.07, 0.12) 0.625 
Physical activity (minutes) -0.01 (-0.03, -0.002) 0.048 + 
5.c Na:K Model 
Univariate regression 
Urinary Na:K ratio 2 0.38 (-0.22, 0.99) 0.209 
Age- and sex-adjusted regression 
Urinary Na:K ratio 2 0.15 (-0.33, 0.64) 0.533 
Sex -0.40 (-1.03, 0.24) 0.218 
Age (years) 0.05 (0.04, 0.07) <0.001 + 
Multivariate regression 
Urinary Na:K ratio 2 0.14 (-0.35, 0.63) 0.573 
Sex -0.41 (-1.03, 0.21) 0.192 
Age (years) 0.04 (0.02, 0.06) <0.001 + 
BMI (kg/m2) 0.04 (-0.04, 0.12) 0.367 
Physical activity (minutes) -0.01 (-0.03, 0.001) 0.063 
1 Na=sodium, BMI=body mass index, K=potassium 
2 From spot urine samples (for further detail see: 4.5.4 spot urine samples) 
+ p-value <0.05 indicates a statistically significantly significant association with PWV 
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5.5 - Association between confounding factors, and PWV 
 
Table 6 and 7 show age was significantly and positively associated with PWV (i.e. a 
1 year increase in age was associated with a 0.05m/s increase in PWV). Furthermore, these 
tables show minutes of physical activity was significantly associated with PWV in both 
potassium models (i.e. a 1-minute increase in physical activity was associated with a 0.01-
































6 - DISCUSSION 
 
The findings of this small study suggest that sodium, potassium, and the sodium-to-
potassium ratio, measured with diet records and spot urine samples, do not independently 
predict PWV. Instead, the present study demonstrates age is the primary determinant of PWV.  
6.1 - Sodium and pulse wave velocity 
 
The present findings are in line with previous research by Dickinson and Keogh 
(2013), Dickinson et al. (2009), Gijsber et al. (2015), Todd et al. (2012), and Wang et al. 
(2014). They utilised interventions comparing low sodium groups consuming 1150-2400mg 
per day, with high sodium groups consuming 3450-7079mg per day, and found sodium has no 
effect on PWV. Dickinson and Keogh (2013), Dickinson et al. (2009), Todd et al. (2012), and 
Wang et al. (2014) recruited normotensive adults, which matches the present normotensive 
sample (mean blood pressure (BP): 127/75mmHg). The previous and present sample likely 
respond similarly to differing sodium intakes, as they are both normotensive, and this may 
explain why the present study supports this research. 
In contrast, He et al. (2009), Jablonski et al. (2013), Seals et al. (2001), and Todd et al. 
(2010), conducted interventions with pre-hypertensive and hypertensive adults. They 
compared low sodium groups consuming 1380-2300mg per day, with high sodium groups 
consuming 3600-4600mg per day, and found high sodium groups have a 0.3-1.43m/s higher 
PWV, suggesting a positive relationship between sodium and PWV. This is supported by 
Polonia et al. (2006), and Sonada et al. (2012), who found a positive association in cross-
sectional trials. 
A possible reason why the present study did not find a positive association between 
PWV and sodium could be due to the methods used to quantify sodium intake. Sodium intake 
was measured with diet records (i.e. 595-6681mg per day) and spot urine samples (i.e. 1233-
4655mg per day). Firstly, the diet record sodium range observed in this study shows extreme 
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low, and high intakes. This may have been caused by the limitations of using diet records. On 
its own, dietary assessment is not considered a reliable measure of sodium intake (University 
of Otago and Ministry of Health 2011), as sodium is difficult to quantify due to the numerous 
ways it is included in the diet (McLean 2014; Weilgosz et al. 2016). Most of the previous 
sodium and PWV literature used dietary assessment, with 24-hour urine urine samples - the 
gold standard measure of electrolyte intake (McLean 2014; Wen et al. 2015; Wielgosz et al. 
2016). However, the present study used spot urine samples. Spot urine samples are known to 
be less reliable than 24-hour samples, as they may only represent intake over a few hours, 
may produce inaccurate data when used on small samples, and have only been validated in a 
few populations (McLean 2014). Given the limitations of these sodium intake measures, it is 
likely the present sodium intake data is unreliable, and hence may be why the present study 
supports a null finding. 
Another reason for the discrepancy in results could be sample size. Previous 
observational studies recruited significantly more participants than the current study, with 
sample sizes ranging from 426-911 participants (Polonia et al. 2006; Sonada et al. 2012), 
compared to the present sample of 65. Although, Polonia et al. (2006), and Sonada et al. 
(2012) do not report a power calculation, it is likely their sample size provided enough power 
to detect a clinically meaningful difference in the PWV of groups with differing sodium 
intakes. The present study required 200 participants to detect a clinically meaningful 
difference, but only 65 participants were included, as that was the number recruited at the 
time of analysis. The present study was therefore likely to be underpowered, which may be 
why no relationship between PWV, and sodium, measured with diet records and spot urine 




6.2 - Potassium and pulse wave velocity 
 
The present findings support research by Berry et al. (2010), Blanch et al. (2014), 
Gijsber et al. (2015), and Wang et al. (2014), who showed potassium supplements, with doses 
ranging from 780-2824mg per day (on top of usual intake) have no effect on PWV.  It is 
possible this study supports this research, as the interventions simulate a usual diet, like what 
was presently observed. Firstly, Berry et al. (2010) and Blanch et al. (2014) used high 
potassium foods, instead of supplements, and Gijsber et al. (2015) and Wang et al. (2014) 
used high sodium intakes in conjunction with high potassium diets. All of which may have 
attenuated potassium’s effect and may explain why the present findings support this research. 
However, several other research groups contradict the above finding. He et al. (2010) 
conducted an intervention study comparing a usual diet group with potassium 
supplementation groups, consuming an additional 2496mg of potassium per day (on top of 
usual intake), as potassium chloride or bicarbonate. They found the chloride group had a 
0.8m/s, and the bicarbonate group had a 0.5m/s lower PWV.  This finding was later supported 
by Graham et al. (2014), who used the same potassium dose, and found it reduced PWV by 
0.4m/s, suggesting an inverse relationship between potassium and PWV. In line with this, 
Dart and Qi (1995), and Lennon-Edwards et al. (2014) found an inverse association using 
cross-sectional study designs.  
A possible reason why the present study did not find an association between PWV and 
potassium, measured with spot urine samples and diet records, could be the present 
observation of usual intake, rather than supplemental intake. The present study observed usual 
potassium intakes, from diet records ranging between 948-6637mg per day, and from spot 
urine samples ranging between 1241-3004mg per day. In contrast, previous intervention trials 
supplemented usual intake with additional 780-2824mg of potassium per day. Given this, the 
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present levels of potassium observed may not have been high enough to find a significant 
inverse association.  
Another reason for the discrepancy between previous and present results could be the 
methods used to quantify potassium intake.  Previous observational studies used 24-hour 
urine sampling (Lennon-Edwards et al.; Dart and Qi 1995), again the gold-standard measure 
of dietary potassium intake (Mizéoun-Adissoda et al. 2016). As mentioned previously, the 
present study used spot urine samples and diet records. Spot urine samples are relatively 
inaccurate due to their limitations mentioned previously (Peng et al. 2016) (for further details 
see: 6.1 sodium and pulse wave velocity). Furthermore, dietary assessment is an accepted 
measure of potassium intake (University of Otago and Ministry of Health 2011), but, diet 
records are still associated with under and over reporting due to social bias, forgetfulness, and 
participant burden (Bentley 2006; McLean 2014). Given this, the present potassium intake 
data may be less reliable than previous research using 24-hour sampling, and may be why the 
present study does not support an association. 
6.3 - Sodium-to-potassium ratio and pulse wave velocity 
 
The present findings are in line with research by Lennon-Edwards et al. (2014), 
Redelinghey et al. (2010), and Tabara et al. (2015), who found no association between the 
sodium-to-potassium ratio and PWV in cross-sectional studies on healthy samples. This is 
further supported by Wang et al. (2014), who conducted an intervention comparing a high 
sodium group consuming 7079mg per day, with a high potassium group consuming the same 
amount of sodium, and 2340mg of supplemental potassium per day.  
It is likely the present study supports research by Lennon-Edwards et al. (2014), 
Redelinghey et al. (2010), and Tabara et al. (2015), as they conducted cross-sectional studies 
and recruited a sample with similar characteristics to the present (i.e. present mean age of 35 
years, compared to 41 years; present mean BP of 127/75mmHg, compared to 124/75mmHg; 
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present mean carotid femoral PWV of 7.2m/s, compared to 6.1 m/s). Where, research who 
found a positive association (Garcia-Ortiz et al. 2012; Wei Zhong, Ning-Ling and Hong-Yi 
2012) conducted cross-sectional studies, recruiting samples with high cardiovascular risk (i.e. 
diabetic and hypertensive adults). Given this, it is possible the previous and present findings 
are explained by the different way hypertensive and normotensive samples respond to 
differing electrolyte intakes.  However, at present, there is not enough evidence to support this 
conclusion, and thus future investigation is required. 
6.4 - Age predicts PWV 
 
The present study found age is a significant predictor of PWV, with PWV increasing 
by 0.05m/s each year. This finding supports the current body of evidence showing a positive 
association between age and PWV (Alghatrif et al. 2013; Cecelja and Chowienczyk 2009; 
Alecu et al. 2006). Benetos et al. (2002), and Asmas et al. (1995), for example, all report that 
on average, PWV increases by 0.1m/s per year. Similarly, Alecu et al. (2006) reports PWV 
increases gradually and continuously until 50 years of age.  
6.5 - Sodium and potassium intake comparison 
 
The present study found mean sodium intakes, measured with spot urine samples and 
diet records, are above the Upper Limit suggesting many New Zealanders are consuming too 
much sodium.  Also, mean potassium intakes are below the Adequate Intake, indicating our 
sample’s potassium intake may be less than adequate (National Health and Medical Research 
and Ministry of Health 2006). The Ministry of Health set sodium and potassium 
recommendations as there is evidence showing an increase in BP with a high sodium, or low 
potassium intake (Sacks et al. 2001; Stamleter et al. 1991; Whelton et al. 1997). As our 
sample’s mean sodium and potassium intakes do not meet Ministry of Health criteria, our 
sample is at risk of increased BP. 
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High sodium, low potassium diets are typical in New Zealand (McLean 2013; McLean 
et al. 2015; University of Otago and Ministry of Health 2011). Most recently, McLean et al. 
(2015) showed a sample of New Zealand had a mean sodium intake of 3865mg per day for 
men and 2934mg per day for women, and a mean potassium intake of 3031mg per day for 
men, and 2436mg per day for women. These data supports the present findings, and 
highlights the need for strategies to reduce sodium and increase potassium intake.  
6.6 - Strengths and limitations 
 
The present study had a number of strengths. Firstly, the present study investigated the 
relationship between PWV and the sodium-to-potassium ratio. Few studies have investigated 
whether the ratio is a better predictor of PWV, and hence the present study addressed this gap. 
Secondly, this study used carotid-femoral PWV, which is the gold-standard measure of 
arterial stiffness (Mancia et al. 2013). The use of this method most likely increased the 
reliability of our data.  
There are several limitations of this study that should be considered when interpreting 
the results. Firstly, this is a cross-sectional study. Therefore, these findings cannot be used to 
establish a longitudinal or causal relationship. Secondly, the present study was limited by its 
sample size, as it did not have enough power to detect a clinically meaningful difference 
between the PWV of groups with differing electrolyte intakes. Thirdly, spot urine samples 
were used instead of 24-hour urine samples. As mentioned above, the estimation equations 
have only been validated in three samples – an elderly Japanese, all female and a Danish 
population (Hooft van Huysduynen et al. 2014; Tanaka et al 2002; Toft et al. 2014). As these 
populations do not match the present sample, the present electrolyte data, measured with spot 
urine samples, is likely to be less reliable.  
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6.7 - Implications for future research 
 
The present study identified areas that have implications for future research. Firstly, 
there are inconsistencies between present and previous findings, and this has identified the 
need for continued investigation of the relationship between dietary electrolytes and PWV. 
Intervention trials provide stronger evidence due to their ability to determine cause and effect. 
Therefore, it is advantageous for more intervention trials that are adequately powered, to be 
conducted in this area, so the exact relationship can be determined.  
Secondly, the use of spot urine samples could have influenced the present findings, as 
the prediction equations have only been validated in three populations (Tanaka et al. 2002; 
Hoof van Huysduynen et al. 2014). Researchers should continue to validate the equations in a 
range of populations. This will ensure spot urine prediction equations can be matched to 
samples, and produce more reliable data. This is important because a validated urinary 
measure is needed to counter the high participant burden associated with 24-hour sampling. 
Thirdly, the present study was limited by its sample size. It is important that future 
researchers recruit a sufficient number of participants to ensure their study has sufficient 
power. The main reason the present study had a small sample size was because only 65 
participants had been recruited by the time of analysis. Therefore, future studies should ensure 
adequate time is allocated to recruitment before analysis is undertaken.   
6.8 - Conclusion 
 
The present study investigated the association between dietary electrolytes, and PWV. 
These findings suggest there is no association between sodium, potassium or the sodium-to-
potassium ratio, and PWV. Given this, the present findings indicate dietary electrolytes do not 
predict arterial stiffness, and rather indict that prediction of PWV is multi-factorial. However, 
the present study was limited by its cross-sectional design, small sample size, dietary 
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assessment and urine collection method. Therefore, the exact relationship between dietary 














































7 - APPLICATION TO PRACTICE 
 
The present findings suggest sodium and potassium intake do not determine arterial 
stiffness independently. However, in light of previous research, the exact relationship between 
electrolyte intake and arterial stiffness remains unclear. As dietitians rely on new findings to 
guide their evidence-based practice, the present findings will add to the evidence base 
regarding micronutrients (i.e. sodium and potassium), and cardiovascular health (i.e. arterial 
stiffness). However, it will not change the way dietitians practice, as there is insufficient 
information to support a low sodium, high potassium diet for improvements in arterial 
stiffness. However, there is still plenty of research to support such a diet in terms of 
improving BP (Tabara et al. 2015), which dietitians should continue to promote one-on-one 
and in group settings.  
The present study also supports previous literature (McLean 2013; McLean 2015; 
University of Otago and Ministry of Health 2011), as it found a sample of New Zealand’s 
population had an average sodium intake above the Upper Limit (>2300mg per day (National 
Health and Medical Research and Ministry of Health 2006) and an average potassium intake 
below the Adequate Intake (<2800mg per day for women, and <3800mg per day for men 
(National Health and Medical Research and Ministry of Health 2006). This highlights the 
need for a population-based strategy to reduce sodium and increase potassium intake. This 
would require the skills of public health dietitians to develop food reformulation (e.g. salt 
reduction in bread), consumer education (e.g. label reading), and behavioural change 
strategies (e.g. reducing table salt use, increasing fruit and vegetable intake) (Lofthouse, Te 
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